Beta-amyloid protein in Alzheimer’s disease. This image shows abnormal accumulation of beta-amyloid in the brain and its impact on neuronal function. In this representation, the neuron, beta-amyloid plaques, tau neurofibrillary tangles, synapse, and cerebral cortex are identified. These structures enable neuronal communication and cognitive processing.
The beta-amyloid protein in Alzheimer’s disease has an altered function in the nervous system. Moreover, under normal conditions, proteins are properly processed. Additionally, neurons maintain efficient communication. Furthermore, this supports proper cognitive function.
On the other hand, in Alzheimer’s disease, beta-amyloid accumulates between neurons. These proteins form extracellular plaques. Moreover, they interfere with synaptic communication. Additionally, they contribute to progressive neuronal damage.
Transport of nerve signals occurs through synapses. For example, electrical impulses allow information transfer between neurons. Moreover, when plaques interfere, this process is disrupted. Additionally, neuronal communication becomes inefficient.
Key processes include beta-amyloid accumulation and tau tangle formation. Moreover, memory loss appears as a primary symptom. However, cognitive impairments are also present. Additionally, functions such as language and orientation are affected.
Regulation depends on genetic and environmental factors. Moreover, aging is the main risk factor. Additionally, other factors may accelerate protein accumulation. Furthermore, progression is gradual.
As a result, neurons progressively deteriorate. Additionally, brain connectivity decreases. Moreover, cognitive capacity is impaired.
Therefore, the beta-amyloid protein in Alzheimer’s disease is central to disease pathophysiology. In conclusion, its accumulation causes neuronal damage and progressive cognitive decline.